Off Body Wearable Injectors Market Analysis, Development, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Off Body Wearable Injectors Market covers analysis by Type (Electronical Injectors, Mechanical Injectors, and Others); End Use (Immuno oncology, Diabetes, Cardiovascular Diseases, and Other), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00014872
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

MARKET OVERVIEW



Wearable injectors are drug delivery equipment based on single-use wearable device technologies produced to deliver drugs in large volume to the patients treated for a long duration. Rapid ongoing developments with many new designed features of these have been witnessed in the medical field. Wearable injectors offer numerous benefits to the patients due to their wide usage. The off-body-worn injectors are applied to the body with the help of belts, while the body-worn patch injectors come with an adhesive that sticks to the body. The needle in the equipment is retractable. The device can be easily discarded once the required dosage is subcutaneously delivered to the patient.

MARKET SCOPE



The "Global Off Body Wearable Injectors Market Analysis to 2031" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Off body wearable injectors market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Off body wearable injectors market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



    - Based on type, the global Off body wearable injectors market is segmented into electronical injectors, mechanical injectors, others.
    - On the basis of end use, the market is segmented into immuno oncology, diabetes, cardiovascular diseases, other.

MARKET DYNAMICS



Drivers



    - Rise in the demand for home healthcare and advanced drug delivery system.
    - Rise in the incidences of several chronic diseases like cancer, diabetes, and CVD.
    - Favorable reimbursement policies.
    - Technological advancements.

Restraints



    - The low dosing volume of administering drugs is the major restraining factor for this market.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Off body wearable injectors market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Off body wearable injectors market in these regions.

IMPACT OF COVID-19 ON OFF BODY WEARABLE INJECTORS MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the Off body wearable injectors market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Off body wearable injectors market are anticipated to lucrative growth opportunities in the future with the rising demand for Off body wearable injectors in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Off body wearable injectors market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    - Becton Dickinson and Company
    - Medtronic
    - Johnson & Johnson
    - Insulet Corporation
    - Unilife Corporation
    - Enable Injections
    - SteadyMed
    - Ypsomed Group
    - West Pharmaceutical Services
    - Unilife

The Insight Partner's dediOff body wearable injectorsed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Off Body Wearable Injectors Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Electronical Injectors
  • Mechanical Injectors
By End Use
  • Immuno oncology
  • Diabetes
  • Cardiovascular Diseases
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Becton Dickinson and Company
  • Medtronic
  • Johnson & Johnson
  • Insulet Corporation
  • Unilife Corporation
  • Enable Injections
  • SteadyMed
  • Ypsomed Group
  • West Pharmaceutical Services
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    off-body-wearable-injectors-market-report-deliverables-img1
    off-body-wearable-injectors-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    Off Body Wearable Injectors Market
    Connect With Expert
    The List of Companies

    1. Becton Dickinson and Company
    2. Medtronic
    3. Johnson & Johnson
    4. Insulet Corporation
    5. Unilife Corporation
    6. Enable Injections
    7. SteadyMed
    8. Ypsomed Group
    9. West Pharmaceutical Services
    10. Unilife
    11. CeQur
    12. Sensile Medical
    13. Roche
    14. ScPharmaceuticals
    15. SteadyMed
    off-body-wearable-injectors-market-cagr